March 23, 2013
View Full PaperSATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours
Key Points
Key points are not available for this paper at this time.
Abstract
SATB2 is a marker of osteoblastic differentiation in benign and malignant mesenchymal tumours. Although SATB2 is not specific for osteosarcoma, it has the potential to be a useful adjunct in some settings, particularly in the distinction between hyalinized collagen and osteoid.